This book deals with the interplay between epigenetic modifications and pharmacogenomic responses. It explores how DNA methylation, histone modification, and non-coding RNAs influence drug efficacy and toxicity. By understanding these epigenetic factors, personalized medicine can be further refined. Targeted towards researchers and clinicians, it bridges the gap between genetic expression and therapeutic outcomes.
Donna Evans is an expert in epigenetics in pharmacogenomics, focusing on how environmental factors and lifestyle influence gene expression and drug response. Her research explores the role of epigenetic modifications in pharmacogenomic variations and how they affect drug efficacy and toxicity. Donna advocates for considering both genetic and epigenetic factors in drug development and patient treatment. She educates researchers and clinicians on the intersection of epigenetics and pharmacogenomics in precision medicine.